Charles Sfeir

Prof. Charles Sfeir


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2014 in Acta Biomaterialia
Verified
Journal Article
Closed access
SYSayuri Yoshizawa
Sayuri Yoshizawa
ABAndrew Brown
Andrew Brown
ABAaron Barchowsky
Aaron Barchowsky
CSCharles Sfeir
Charles Sfeir

1 May 2015 in Acta Biomaterialia
Verified
Journal Article
Closed access
ACAmy Chaya
Amy Chaya
SYSayuri Yoshizawa
Sayuri Yoshizawa
KVKostas Verdelis
Kostas Verdelis
NMNicole Myers
Nicole Myers
BCBernard J. Costello
Bernard J. Costello
CSCharles Sfeir
Charles Sfeir

4 November 2018 in Journal of Dental Research
Verified
Journal Article
Closed access
ZZZhe Zhuang
Zhe Zhuang
SYS. Yoshizawa-Smith
S. Yoshizawa-Smith
AGA. Glowacki
A. Glowacki
KMK. Maltos
K. Maltos
CPC. Pacheco
C. Pacheco
CSCharles Sfeir
Charles Sfeir
Periodontitis is characterized by the progressive destruction of tooth-supporting alveolar bone, which is mainly caused by chronic inflammation in response to persistent bacterial insult. It has recently become clear that the pathogenesis of periodontitis is associated with a high ratio of proinflammatory M1 (classically activated) macrophages to anti-inflammatory M2 (alternatively activated). To decrease the inflammatory activity, we locally delivered the C-C motif chemokine ligand 2 (CCL2) using controlled-release microparticles (MPs). CCL2 is known to promote chemotaxis of M0 or M2 phenotype macrophages to the inflamed site and induce M2 phenotype polarization locally. Our in vitro data showed that CCL2 increased the number of M2 phenotype macrophages, decreased TNF-α secretion, and enhanced chemotaxis of RAW264.7 cells toward CCL2 MPs. Moreover, we induced periodontal disease in 2 animal models through inoculation of Porphyromonas gingivalis and ligature around the murine molar. Micro–computed tomography analysis showed significant reduction of alveolar bone loss in the CCL2 MP treatment group when compared with a blank MP group and a no-treatment periodontitis group in both models. Immunohistologic analysis showed a significant increase in the M2 phenotype subset and a decrease in the M1 phenotype subset in the CCL2 MP group of the P. gingivalis–induced model. Also, in both models, tartrate-resistant acidic phosphatase staining showed significantly fewer numbers of osteoclasts in the CCL2 MP group in alveolar bone area. Moreover, quantitative polymerase chain reaction results showed a significant increase in IL-1RA (interleukin 1 receptor antagonist) mRNA expression and a decrease in RANKL (receptor activator of nuclear factor kappa-Β ligand) mRNA expression in the CCL2 MP group in the ligature model. In summary, manipulation of endogenous M2 phenotype macrophages with CCL2 MPs decreased the M1 phenotype:M2 phenotype ratio and prevented alveolar bone loss in mouse periodontitis models. The delivery of CCL2 MPs provides a novel approach to treat periodontal disease.

1 October 2019 in Acta Biomaterialia
Verified
Journal Article
Closed access
CHChu-Chih Hung
Chu-Chih Hung
ACAmy Chaya
Amy Chaya
KLKai Liu
Kai Liu
KVKonstantinos Verdelis
Konstantinos Verdelis
CSCharles Sfeir
Charles Sfeir

1 January 2015 in Acta Biomaterialia
Verified
Journal Article
Closed access
ABAndrew Brown
Andrew Brown
Samer of ZakySamer of Zaky
Samer of Zaky
HRHerbert Ray
Herbert Ray
CSCharles Sfeir
Charles Sfeir

8 July 2011 in Biomacromolecules
Verified
Journal Article
Closed access
ADAtul Suresh Deshpande
Atul Suresh Deshpande
PFPing-An Fang
Ping-An Fang
XZXiaoyuan Zhang
Xiaoyuan Zhang
TJThottala Jayaraman
Thottala Jayaraman
CSCharles Sfeir
Charles Sfeir
EBElia Beniash
Elia Beniash